Description
The firm is aiming to develop lab methodologies that are applicable for oligonucleotide separation and its purification. These methods will be applicable depending on the length of the oligonucleotide synthesized and degree of purity requir…
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02021-10-01$30,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2021-10-01(start date) | $30,000 | — | The firm is aiming to develop lab methodologies that are applicable for oligonucleotide separation and its pur… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 717183537)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2025-2026-Q4-515743 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund Contributions | $6,037,700 | FY2026 |
| 172-2025-2026-Q2-1032265 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $498,000 | FY2026 |
| 033-2023-2024-Q2-819504 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream 2 - Growth | $15,000,000 | FY2024 |
| GC-WD-DEO-2022-2023-Q4-6 | Prairies Economic Development Canada | Développement économique Canada pour les Prairies · Regional Economic Growth through Innovation | $5,000,000 | FY2023 |
| 172-2022-2023-Q4-1003190 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $7,000,000 | FY2023 |
| 172-2021-2022-Q1-973217 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program | $60,000 | FY2022 |
Other recipients funded under "Industrial Research Assistance Program – Youth Employment Program" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1043891 | Ripple Therapeutics Corporation | FY2027 | $25,000 | FY2027 |
| 172-2026-2027-Q1-1044015 | BackSCNR Inc. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043828 | Marwood Ltd. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043785 | PURITY-IQ INCORPORATED | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1044062 | Smart City Water Inc. | FY2027 | $30,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q3-979998 · retrieved 2026-11-12.